Eva Revilla-Lopez
Overview
Explore the profile of Eva Revilla-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boada-Perez M, Berastegui C, Erro M, Ussetti P, Crespo E, Donadeu L, et al.
Front Immunol
. 2025 Feb;
15:1445553.
PMID: 39911579
Introduction: Risk stratification for CMV infection in lung transplantation (LT) currently relies on determining donor and recipient CMV IgG before transplantation. However, it has been observed that some patients who...
2.
Boada-Perez M, Ruiz de Miguel V, Erro M, Ussetti P, Aguilar M, Castejon R, et al.
Front Immunol
. 2024 May;
15:1382459.
PMID: 38799459
Introduction: Trough blood levels (C) of tacrolimus are used to adjust drug dosage, but they do not consistently correlate with clinical outcomes. Measurement of residual gene expression of nuclear factor...
3.
Revilla-Lopez E, Ruiz de Miguel V, Lopez-Meseguer M, Berastegui C, Boada-Perez M, Mendoza-Valderrey A, et al.
Front Med (Lausanne)
. 2023 Feb;
10:1079317.
PMID: 36817769
Background: Vascular endothelial growth factor-D (VEGF-D) is the most commonly used biomarker for diagnosing lymphangioleiomyomatosis (LAM). However, lung biopsy is often necessary as well; therefore, defining new biomarkers for LAM...
4.
Guillen-Del-Castillo A, Lopez Meseguer M, Fonollosa-Pla V, Saez Gimenez B, Colunga-Arguelles D, Revilla-Lopez E, et al.
Sci Rep
. 2022 Jul;
12(1):12947.
PMID: 35902683
No abstract available.
5.
Guillen-Del-Castillo A, Lopez Meseguer M, Fonollosa-Pla V, Saez Gimenez B, Colunga-Arguelles D, Revilla-Lopez E, et al.
Sci Rep
. 2022 Mar;
12(1):5289.
PMID: 35347225
To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc...
6.
Saez-Gimenez B, Clofent D, Lopez Meseguer M, Bravo Masgoret C, Monforte V, Berastegui C, et al.
Respir Med
. 2021 Sep;
188:106584.
PMID: 34560353
Background: Venous thromboembolism (VTE) is a major complication after lung transplantation (LT). However, its pathophysiology remains unknown, and coagulation profiles have yet to be described. Objective: The aim of this...
7.
Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson S, et al.
EMBO Mol Med
. 2021 Aug;
13(9):e13929.
PMID: 34378323
Inhibition of mTOR is the standard of care for lymphangioleiomyomatosis (LAM). However, this therapy has variable tolerability and some patients show progressive decline of lung function despite treatment. LAM diagnosis...
8.
Revilla-Lopez E, Berastegui C, Mendez A, Saez-Gimenez B, Ruiz de Miguel V, Lopez-Meseguer M, et al.
Sci Rep
. 2021 May;
11(1):10171.
PMID: 33986388
There are few published data on long-term treatment with sirolimus in lymphangioleiomyomatosis (LAM). The objective of this study was to describe the long-term effect of sirolimus in a series of...
9.
Donadeu L, Revilla-Lopez E, Jarque M, Crespo E, Torija A, Bravo C, et al.
J Infect Dis
. 2020 Nov;
224(3):526-531.
PMID: 33245359
Monitoring cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) is useful in predicting late-onset CMV infection after solid organ transplantation, but few data have been reported after lung transplantation (LT). CMV CMI against...
10.
Saez-Gimenez B, Berastegui C, Barrecheguren M, Revilla-Lopez E, Arcos I, Alonso R, et al.
Am J Transplant
. 2020 Oct;
21(5):1816-1824.
PMID: 33089648
This study describes the clinical presentation, treatment, and outcomes of SARS-CoV-2 infection in lung transplant recipients (LTRs). This is a multicenter, retrospective study of all adult LTRs with confirmed SARS-CoV-2...